The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 901 through 910 of 961 results (Download Results)

Show results per page

Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

James, Michael N | University of Alberta | Operating Grant | $311,000

CIHR Alberta 2020

Interventions numériques pour détecter, prévenir et prendre en charge les problèmes de santé mentale chez les personnes atteintes de maladies chroniques : Synthèse des connaissances

Gagnon, Marie-Pierre | Université Laval | Operating Grant | $49,992

CIHR Quebec 2020

CovidFree@Home: Development and validation of a multivariable prediction model of deterioration in patients diagnosed with COVID‑19 who are managing at home

Gershon, Andrea S | Sunnybrook Research Institute | Operating Grant | $524,012

CIHR Ontario 2020

Digital Health Solutions to Support Women with Addiction During COVID-19: Applying a Gender- and Trauma-Informed Lens

Quilty, Lena C | Centre for Addiction and Mental Health | Operating Grant | $50,000

CIHR Ontario 2020

A mixed methods evaluation of risk mitigation measures to address the dual public health crises of COVID‑19 and overdose

Slaunwhite, Amanda K | B.C. Centre for Disease Control | Operating Grant | $852,439

CIHR British Columbia 2020

Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2

Watts, Tania H | University of Toronto | Operating Grant | $1,329,250

CIHR Ontario 2020

Sex as a Biological Variable Supplement – Reducing the Health Care Resource Burden from COVID‑19 (SARS-CoV-2): Rapid Diagnostics to Risk-Stratify for Severity of Illness

Keshavjee, Shaf | University Health Network | Operating Grant | $50,000

CIHR Ontario 2020

Digital Virtual Support of Cases and Contacts to Novel Coronavirus (COVID-19): Readiness and Knowledge Sharing for Global Outbreaks (WelTel PHM)

Lester, Richard T | University of British Columbia | Operating Grant | $500,000

CIHR British Columbia 2020

Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

Ng, Kenneth K | The University of Calgary | Operating Grant | $416,000

CIHR Alberta 2020

INTERCEPTORs: engINeered ThERapeutiC dEfensive Particles TO SARS-CoV-2

Sonenberg, Nahum | McGill University | Operating Grant | $745,124

CIHR Quebec 2020

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Towards anti-COVID-19 therapeutic development by targeting the viral papain-like proteinase

Interventions numériques pour détecter, prévenir et prendre en charge les problèmes de santé mentale chez les personnes atteintes de maladies chroniques : Synthèse des connaissances

CovidFree@Home: Development and validation of a multivariable prediction model of deterioration in patients diagnosed with COVID‑19 who are managing at home

Digital Health Solutions to Support Women with Addiction During COVID-19: Applying a Gender- and Trauma-Informed Lens

A mixed methods evaluation of risk mitigation measures to address the dual public health crises of COVID‑19 and overdose

Towards a comprehensive understanding of adaptive immunity to SARS-CoV-2

Sex as a Biological Variable Supplement – Reducing the Health Care Resource Burden from COVID‑19 (SARS-CoV-2): Rapid Diagnostics to Risk-Stratify for Severity of Illness

Digital Virtual Support of Cases and Contacts to Novel Coronavirus (COVID-19): Readiness and Knowledge Sharing for Global Outbreaks (WelTel PHM)

Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

INTERCEPTORs: engINeered ThERapeutiC dEfensive Particles TO SARS-CoV-2